|
Call
for Scientific and Best Practice Abstracts
All practitioners/investigators
in the field of pediatric clinical pharmacy, whether members of
PPAG or not, are invited to submit abstracts of papers to be considered
for platform or poster presentation at the 17th PPAG Annual Meeting,
October 2-5, 2008 at the Renaissance Harborplace Hotel, Baltimore,
Maryland
All research
and practice abstracts should be no longer than 450 words. Scientific
and Practice Abstracts will be published in the Journal of Pediatric
Pharmacology and Therapeutics. Platform presentations and Best Practice
Awards will be chosen from the abstracts submitted.
The Pediatric
Pharmacy Advocacy Group is pleased to offer "Guidelines for
Abstract Preparation." Please
click here for the Guidelines.
The deadline
to submit abstracts is June 30, 2008
SUBMIT
YOUR ABSTRACT HERE
About
Research/Scientific Abstracts
Research
abstracts presented at PPAG report the results of a scientific investigation
or a clinical observation (case report) involving some aspect of
pharmacotherapy. Scientific investigations can be either clinical,
basic, or translational and are either hypothesis-driven or descriptive
in nature. To be accepted for presentation, research abstracts must
have either preliminary or final results. The abstract may be submitted
in any of the following categories: Scientific, Case Report, and
Encore Presentations (a poster that has been presented and published
elsewhere. The original citation must accompany encore presentations).
Students,
Residents and Fellows whose research projects are ongoing at the
time of submission but do not have preliminary results are encouraged
to submit in the Research-in-Progress category. Abstracts accepted
in this category will not be published in the Journal of Pediatric
Pharmacy and Therapeutics. However, if such projects do have preliminary
or final results, they should be submitted in Original Research,
or Encore Presentation category.
All submissions,
except those in Research-in Progress and encore categories, will
be eligible for the Young Investigator or Best Original Paper award.
The finalists will be judged by a panel of judges during the poster
and platform presentation sessions.
For more
information about Research Abstracts, please
click here. [Note: This link will take you back to the
PPAG website].
About
Best/Innovative Practice Abstracts
Best
and Innovative Pediatric Pharmacy Practice Abstracts typically describe
programs, systems, or projects that are innovative, creative, cost-effective,
and improve practice in pediatric pharmacy. BIPA Posters will be
selected based on achievement of excellence in each of the four
areas.
Winners
of the Best Practice Award will be chosen from accepted abstracts.
The program, system, or project can be an individual or collaborative
effort in any type of practice setting, including academia, institutional,
or ambulatory care. Unlike Research Abstracts, Best Practice Abstracts
are not required to have final or preliminary data, but should include
sufficient details about the rationale, process, and hypothesis
of the impact should the program, system, or project be implemented.
For more
information about Practice Abstracts, please
click here. [Note: This link will take you back to the
PPAG website].
|
